A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise
Jung, Chang Hee, Park, Cheol-Young, Ahn, Kyu-Joeng, Kim, Nan-Hee, Jang, Hak-Chul, Lee, Moon-Kyu, Park, Joong-Yeol, Chung, Choon-Hee, Min, Kyung-Wan, Sung, Yeon-Ah, Park, Jeong-Hyun, Kim, Sung Jin, Lee, Hyo Jung, Park, Sung-Woo
Published in Diabetes/metabolism research and reviews (01.03.2015)
Published in Diabetes/metabolism research and reviews (01.03.2015)
Get full text
Journal Article